Application of plant lactobacillus Mle-3, composition and composite microbial preparation

Through the combination of Mle-3 in plant lactobacterium Mle-3 and other strains and the combination of specific ingredients, a complex microbial preparation is formed, which solves the problem of insufficient antioxidant function stability of lactic acid bacteria, and significantly improves the antioxidant ability and the stability of probiotics. Suitable for a variety of applications.

CN118948905APending Publication Date: 2024-11-15HANGZHOU JUNWU XIYAN BIOTECHNOLOGY CO LTD
View PDF 11 Cites 0 Cited by

Patent Information

Application Number
CN202411436412.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-15
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The antioxidant function of existing lactic acid bacteria is insufficient and the probiotic function is single, which limits its actual effect in the human body.

Method used

Using Mle-3 in planta planta, Lactobacillus MLL-6 in planta and Bifidobacterium brevis, combined with sodium alginate, end-carboxypolyamide, glutathione and active polysaccharide, to form a complex microorganism through specific preparation methods Formulation, enhance antioxidant ability and adhesion properties.

Benefits of technology

It significantly improves the total antioxidant capacity, enhances the body's immunity, improves the antioxidant activity and the stability of probiotics. It is suitable for microbial preparations, food and medicines, and can play a stable role in the long term.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948905A_ABST
    Figure CN118948905A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of microbial engineering, and particularly discloses application of plant lactobacillus Mle-3, a microbial composition, a composite microbial preparation and a preparation method of the composite microbial preparation. The lactobacillus plantarum Mle-3 is applied to any one of the following items (1) to (5): (1) preparing an anti-oxidation product, (2) preparing an anti-oxidation product, (3) preparing an anti-oxidation product, (4) preparing an anti-oxidation product, (5) preparing an anti-oxidation product, (5) preparing an anti-oxidation product and (6) preparing an anti-oxidation product. (2) preparing an anti-aging product; (3) preparing a product for repairing colonic mucosa; (4) preparing a product for inhibiting the growth of the Helicobacter (Helicobacter) or / and the unclassified murine bacillus (unclassified murine bacillus) in the intestinal tract, and preparing a product for inhibiting the growth of the Helicobacter (Helicobacter) or / and the unclassified murine bacillus (unclassified murine bacillus) in the intestinal tract; and (5) preparing a product for promoting the growth of the prevoteraceae UCG-001 family or / and the prevoteraceae NK3B31 family in the intestinal tract.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of microbial engineering, and in particular to an application of Lactobacillus plantarum Mle-3, a microbial composition, a composite microbial preparation and a preparation method thereof. Background Art

[0002] Since pathogenic bacteria and conditional pathogens multiply in large numbers, they can cause various diseases in the human body. Studies have shown that probiotics have the unique ability to compete with intestinal pathogens and pathogenic microorganisms for adhesion, regulate fat storage and stimulate intestinal angiogenesis, maintain the stability of intestinal flora, reduce lactose intolerance, prevent antibiotic-induced diarrhea, prevent colon cancer, improve immunity, lower cholesterol, and treat depression, Parkinson's disease and other diseases related to the brain's nerve center.

[0003] Oxidative stress and the oxidative damage it causes have become a highly concerned pathological condition. Lactic acid bacteria is a general term for Gram-positive bacteria that can ferment carbohydrates and produce a large amount of lactic acid. It is currently recognized as a safe edible fungus. Existing studies have shown that lactic acid bacteria, as resident intestinal flora, can directly exert an antioxidant effect in the intestine, a key part of the body that is oxidatively damaged, and maintain the intestine in a state of redox balance.

[0004] Lactic acid bacteria exert their antioxidant effects in the body mainly through the following pathways: through their own antioxidant enzyme system; forming macromolecular or small molecule metabolites with reducing activity or regulating oxidative stress; regulating the expression level of redox balance regulators by transducing cell signals through metabolites; regulating intestinal flora to inhibit the formation of oxidative stress.

[0005] Although the body can effectively enhance its antioxidant capacity through dietary supplementation of antioxidants, many chemically synthesized antioxidants have safety issues. As a natural antioxidant, lactic acid bacteria have attracted more and more attention due to their ability to reduce the generation of reactive oxygen species.

[0006] Although many strains of lactic acid bacteria with antioxidant function have been screened out, they often enter the body through the mouth, lack stability, and have insufficient antioxidant effect on the body; at the same time, their prebiotic function is single and unclear, which limits the actual efficacy of lactic acid bacteria.

[0007] Therefore, screening out lactic acid strains with high antioxidant capacity and enhancing their stability and adhesion are of great significance for enhancing the body's antioxidant capacity. Summary of the invention

[0008] The purpose of the present invention is to solve the shortcomings of the prior art and to propose an application of Lactobacillus plantarum Mle-3, a microbial composition, a composite microbial preparation and a preparation method thereof.

[0009] Lactobacillus plantarum ( Lactiplantibacillus plantarum ) Application of Mle-3 in any of the following (1)-(5): (1) Preparation of antioxidant products; (2) Preparation of anti-aging products; (3) preparing products for repairing colon mucosa; (4) Preparation of Helicobacter spp. Helicobacter ) and / or unclassified Rhabditiaceae ( unclassified_Muribaculaceae ) products grown; (5) Preparation of the UCG-001 family of the family Prevotellaceae to promote intestinal Prevotellaceae_UCG_001 ) or / and Prevotellaceae NK3B31 family ( Prevotellaceae_NK3B31_group ) products grown.

[0010] Preferably, Lactobacillus plantarum Mle-3 is deposited in the General Microbiology Center of China National Microbiological Culture Collection Administration with the deposit number of CGMCC NO.30556.

[0011] Preferably, the product is a microbial preparation, a health food or a medicine.

[0012] A microbial composition comprises: the Lactobacillus plantarum Mle-3.

[0013] Preferably, the above-mentioned microbial composition further comprises: Lactobacillus plantarum ( Lactiplantibacillus plantarum )MLL-6, Bifidobacterium breve ( Bifidobacterium breve ).

[0014] Preferably, in the above microbial composition, the number of viable bacteria of Lactobacillus plantarum Mle-3 is 5-15×10 9 cfu / g, and the number of viable bacteria of Lactobacillus plantarum MLL-6 was 2-6×10 9 cfu / g, the number of viable bacteria of Bifidobacterium breve is 9-14×10 8 cfu / g.

[0015] A composite microbial preparation, whose raw materials include, by mass: 1-2 parts of the above microbial composition, 1-2 parts of sodium alginate, 1-3 parts of carboxyl-terminated polyamidoamine, 0.1-1 part of glutathione, 0.1-0.5 parts of active polysaccharide, and 0.08-0.24 parts of calcium chloride.

[0016] Preferably, the active polysaccharide is pine pollen polysaccharide.

[0017] The preparation method of the above-mentioned composite microbial preparation comprises the following steps: S1. Add glutathione to hydrochloric acid and stir evenly, add pine pollen polysaccharide thereto, stir at 80-90°C for 10-20 minutes, cool to room temperature, filter, wash, and vacuum dry to obtain activated polypeptide; S2, adding the above-mentioned microbial composition, sodium alginate, carboxyl-terminated polyamidoamine, and activated polypeptide into water and stirring for 20-30 minutes to obtain an aqueous phase material; S3. Continue stirring the oil phase, and add the water phase material and calcium chloride aqueous solution in sequence during the continuous stirring process. Continue stirring for 5-15 minutes after the addition is complete, let stand at 40-45°C for 2-4 hours, filter, wash, and freeze-dry.

[0018] Preferably, in S3, the oil phase is at least one of peanut oil, rapeseed oil, soybean oil, corn oil, camellia oil, walnut oil, olive oil, palm oil, grapeseed oil, and sunflower oil.

[0019] Preferably, in S3, the mass fraction of the calcium chloride aqueous solution is 8-12%. Beneficial effect: The present invention provides the above-mentioned plant lactobacillus Mle-3, which has a strong antioxidant capacity, much higher than that of existing strains, and can enhance the total antioxidant capacity, reduce the content of hydroxyl radicals, superoxide anions and malondialdehyde in serum, and increase the activity of glutathione peroxidase and catalase in serum, thereby improving the body's immunity.

[0020] The applicant has found that the combination of Lactobacillus plantarum Mle-3 with Lactobacillus plantarum MLL-6 and Bifidobacterium breve exhibits good synergistic behavior, allowing the resulting microbial composition to colonize in the intestine and exert extremely strong antioxidant activity in the body.

[0021] The present invention grafts active polysaccharides onto glutathione, which can not only significantly enhance the stability of glutathione, but also compound with terminal carboxyl polyamide amine. The two form a network through bonding, effectively capture the microbial composition, and solidify with the cooperation of sodium alginate to form a spatial structure, which can not only stably load the microbial composition, but also effectively slow-release it.

[0022] The composite microbial preparation obtained by the present invention has good bile salt tolerance, and the survival rate of the strain in artificial gastric juice and intestinal juice is high, which is much higher than that of the existing strains, and the activity of the microbial composition can be stably exerted for a long time. At the same time, it has excellent adhesion performance, good growth and colonization effects, and significantly enhances the antioxidant activity of probiotics. It can be widely used in microbial preparations, foods, health foods and medicines, improves the body's antioxidant capacity and immunity, and is suitable for large-scale promotion and application. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 This is a photo of the colony morphology of Lactobacillus plantarum Mle-3.

[0024] Figure 2 This is a microscopic photo of Lactobacillus plantarum Mle-3.

[0025] Figure 3 This is the curve of the survival rate of Lactobacillus plantarum Mle-3 changing with pH value.

[0026] Figure 4 This is the bile salt tolerance curve of Lactobacillus plantarum Mle-3.

[0027] Figure 5 This is a graph showing the changes in intestinal microbial community genus level in the normal control group, aging model group, and Mle-3 treatment group.

[0028] Figure 6 This is a comparison of HE staining of mouse tissue sections in the normal control group, aging model group, and Mle-3 treatment group.

[0029] Figure 7 This is a comparison chart of the intestinal acetic acid and propionic acid contents of mice in the normal control group, aging model group, and Mle-3 treatment group.

[0030] Figure 8 This is a comparison chart of intestinal isobutyric acid and butyric acid contents in the normal control group, aging model group, and Mle-3 treatment group of mice.

[0031] Fig. 9 This is a comparison chart of the intestinal isovaleric acid and valeric acid contents of mice in the normal control group, aging model group, and Mle-3 treatment group.

[0032] Fig.10 This is a comparison chart of serum glutathione peroxidase activity and glutathione peroxidase inhibition rate in mice of the normal control group, aging model group, and Mle-3 treatment group.

[0033] Fig.11 This is a comparison chart of the superoxide anion inhibition activity and superoxide anion inhibition rate of mouse serum in the normal control group, aging model group, and Mle-3 treatment group.

[0034] Fig.12 This is a comparison chart of serum catalase activity and hydroxyl radical scavenging ability of mice in the normal control group, aging model group, and Mle-3 treatment group.

[0035] Fig.13 This is a comparison chart of serum DPPH clearance and malondialdehyde content in mice of the normal control group, aging model group, and Mle-3 treatment group.

[0036] Fig.14 It is a comparison chart of the embedding rate of the composite microbial preparation obtained in Example 10 and Comparative Examples 1-2.

[0037] Fig.15This is a comparison chart of the index of the number of live bacteria in the composite microbial preparations obtained in Example 10 and Comparative Examples 1-2 after bile salt treatment.

[0038] Fig.16 This is a comparison chart of the survival rates of the composite microbial preparations obtained in Example 10 and Comparative Examples 1-2 after being treated with in vitro simulated digestive fluid.

[0039] Fig.17 This is a comparison chart of serum glutathione peroxidase activity and glutathione peroxidase inhibition rate of mice in the normal control group, aging model group, SS10 group, DB1 group, and DB2 group.

[0040] Fig.18 This is a comparison chart of the inhibition of superoxide anion activity and superoxide anion inhibition rate of mouse serum in the normal control group, aging model group, SS10 group, DB1 group, and DB2 group.

[0041] Fig.19 This is a comparison chart of the inhibition of superoxide anion activity and superoxide anion inhibition rate by mouse serum in the normal control group, SS10 group, DB1 group, and DB2 group.

[0042] Fig. 20 This is a comparison chart of serum catalase activity and hydroxyl radical scavenging ability of mice in the normal control group, aging model group, SS10 group, DB1 group, and DB2 group.

[0043] Fig.21 This is a comparison chart of serum catalase activity and hydroxyl radical scavenging ability of mice in the normal control group, SS10 group, DB1 group, and DB2 group.

[0044] Fig. 22 This is a comparison chart of serum DPPH clearance and malondialdehyde content in mice of the normal control group, aging model group, SS10 group, DB1 group, and DB2 group. DETAILED DESCRIPTION

[0045] The present invention will be further explained below in conjunction with specific embodiments.

[0046] The following Lactobacillus plantarum ( Lactiplantibacillus plantarum ) The deposit number of MLL-6 is CGMCC NO. 30469, which is isolated by the applicant (Hangzhou Junwu Xiyan Biotechnology Co., Ltd.).

[0047] The following Bifidobacterium breve ( Bifidobacterium breve ) with a deposit number of CGMCC NO.1.3001, purchased from the General Microbiology Center of China National Microbiological Culture Collection Administration.

[0048] Example 1: The strain was isolated and collected by Huang Dasheng from homemade fermentation broth in Shangcheng District, Hangzhou City, Zhejiang Province, China in December 2023.

[0049] Isolation and purification of strains: Pipette 100 μL of the well-mixed fermentation broth and add it to an EP tube containing 900 μL of sterile water. -4 , 10 -5 Perform plate spreading (MRS) and culture inverted in a 37°C anaerobic incubator for 48-72 hours.

[0050] Observe the bacterial growth on the plate. After the colonies grow, pick a typical single colony and streak it on MRS solid medium for strain isolation and purification. Inoculate the single colony into 5 mL of sterilized MRS broth medium, incubate at 37°C for 48 hours, and then store it in a -80°C refrigerator with 50% glycerol for later use.

[0051] The isolated strains were identified by morphology (colony morphology such as Figure 1 As shown, the microscopic morphology Figure 2 as shown).

[0052] The isolated and purified single colonies were sent to Zhejiang Shangya Biotechnology Co., Ltd. for sequencing identification. The primers are as follows: 27F: 5'-AGAGTTTGATCMTGGCTCAG-3'; 1492R: 5'-GGTTACCTTGTTACGACTT-3'.

[0053] Its ITS / 16s sequence is as follows: The BLAST program in NCBI was used to compare the Mle-3 sequence, and the results showed that the strain was Lactobacillus plantarum, with a homology of 99.93% with the known Lactobacillus plantarum in the GeneBank database. It was named Lactobacillus plantarum ( Lactiplantibacillus plantarum )Mle-3.

[0054] Lactobacillus plantarum Mle-3 was deposited in the General Microbiology Center of China Culture Collection Administration (Institute of Microbiology, Chinese Academy of Sciences, No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing) on ​​May 11, 2024, with the deposit number CGMCC NO.30556.

[0055] Example 2 Effect of different pH on strain survival rate Lactobacillus plantarum Mle-3 was inoculated at a 2% inoculation rate into MRS culture medium with initial pH=3.0, pH=4.0, pH=5.0, pH=6.0, and pH=7.0, respectively. After anaerobic culture at 37°C for 24 h, the OD value of the strain in the culture medium with different initial pH values ​​was measured at a wavelength of 600 nm to analyze its tolerance level.

[0056] like Figure 3 As shown, with the increase of pH, the reproduction ability of Lactobacillus plantarum Mle-3 first increased and then decreased, and the environment of pH=6 was most suitable for the reproduction and growth of Lactobacillus plantarum Mle-3.

[0057] Example 3 Effects of different bile salt concentrations on the bile salt tolerance of strains Add 0.2% ( w / v ) sodium thioglycolate, and then continue to add 0%, 0.03%, 0.1%, 0.2%, 0.3% ( w / v ) was added with bile salt No. 3 to adjust the pH to 7.2, and MRS liquid culture medium without bile salt was used as a control.

[0058] The suspension of Lactobacillus plantarum Mle-3 was diluted to 2% ( v / v ) were added to MRS liquid culture medium containing different bile salt concentrations, and three parallel replicate groups were set up and placed in anaerobic culture at 37°C for 24 hours. MRS liquid culture medium was used as a blank control, and the OD value of the strain in the culture medium with different bile salt concentrations was measured at a wavelength of 600nm to analyze the tolerance level and calculate the bile salt tolerance ability.

[0059] Among them, A1 is the OD value of the medium containing bile salts, and A0 is the OD value of the medium without bile salts.

[0060] like Figure 4As shown, Lactobacillus plantarum Mle-3 has a weak tolerance to bile salts. As the bile salt concentration increases, the growth and reproduction ability of Lactobacillus plantarum Mle-3 weakens.

[0061] Example 4 Detection of antioxidant index (DPPH clearance rate) Lactobacillus plantarum Mle-3 was inoculated into MRS medium at a 2% inoculum volume, and after culturing at 37°C for a certain period of time, the bacteria were taken out and centrifuged and washed. 600 The value was adjusted to 1.0, and the culture was re-inoculated into MRS medium at a 2% inoculum and cultured at 37°C for 24 hours. The cultured bacterial solution was centrifuged at 12000 r / min for 5 minutes, and then the supernatant was obtained using a 0.22 μm bacterial filter.

[0062] Then, 1 mL of the supernatant was gently aspirated using a pipette, and 1 mL of 0.02 mmol / L DPPH solution was added. The mixture was reacted for 30 min in the dark, centrifuged at 4000 rpm for 10 min, and 200 μL was taken to measure the absorbance at 517 nm.

[0063] Among them, A i is the absorbance of 1mL DPPH + 1mL sample, A j is the absorbance of 1mL PBS + 1mL sample, A c It is the absorbance of 1mL DPPH + 1mL PBS.

[0064] The DPPH scavenging rate of the supernatant of Lactobacillus plantarum Mle-3 reached 95.3619±0.6180%, indicating that the supernatant of Lactobacillus plantarum Mle-3 has excellent antioxidant capacity.

[0065] Example 5 Determination of total antioxidant capacity (total T-AOC) An appropriate amount of the supernatant obtained in Example 4 was taken and the total T-AOC was determined according to the instructions of the kit (Nanjing Jiancheng Bioengineering Institute, catalog number: A015-3-1).

[0066] OD of supernatant of Lactobacillus plantarum Mle-3 593 was 1.280, while the OD of the suspension of Lactobacillus plantarum Mle-3 was 593 is 0.149, that is, OD 593 The total value is 1.429. According to the FeSO4 standard curve, it can be concluded that the total antioxidant capacity of Lactobacillus plantarum Mle-3 is 4.043nM.

[0067] Example 6: Eight 12-week-old male C57BL6 mice were taken as a normal control group (CK), and 16 40-week-old male C57BL6 mice were randomly divided into two groups, namely an aging model group (MC) and a Mle-3 treatment group.

[0068] Each group of experimental animals had 4 animals per cage, room temperature was 23-25℃, humidity was 40-45%, light was on for 12h per day, food and water were freely available, and bedding was changed regularly. The mice were adaptively fed for 1 week, and the intervention lasted for 14 weeks (98 days).

[0069] The groups and interventions are shown in Table 1: Table 1 Intervention treatment of normal control group, aging model group and Mle-3 treatment group: Among them, the basic feed includes: 25% bran, 20% flour, 20% corn, 20% soybean feed, 10% rice flour, 2.5% fish meal, and 2.5% bone meal.

[0070] One day before the end of the experiment, collect 3-5 pieces of mouse feces and fast the mice for less than 12 hours. Then store the collected feces at -80℃ and send them for 16S rRNA gene high-throughput sequencing to analyze the structure of mouse intestinal flora.

[0071] After the experiment, the colon of the mice was collected and the colon was sliced ​​for H&E staining. The contents of the mouse cecum were collected to determine the level of short-chain fatty acids (SCFA). The blood of the mice was collected and temporarily stored in EDTA-K tubes to determine the glutathione peroxidase activity, glutathione peroxidase inhibition rate, catalase activity, superoxide anion inhibition activity, malondialdehyde content and hydroxyl free radical scavenging ability in the serum.

[0072] like Figure 5 As shown, the intestinal microbial communities of mice in the normal control group (CK), aging model group (MC) and Mle-3 treatment group changed significantly.

[0073] Lactobacillus is a probiotic that can utilize carbohydrates in the intestine to produce acidic metabolites, lower intestinal pH, improve the intestinal microbial environment, and regulate the host immune system.

[0074] from Figure 5 It can be seen that the proportion of lactic acid bacteria in the intestine of the mice in the Mle-3 treatment group increased significantly compared with the aging model group (MC), and was basically the same as that in the normal control group (CK), indicating that due to natural aging, the proportion of Lactobacillus in the intestine of mice ( Lactobacillus) content was significantly reduced, while daily gavage of Lactobacillus plantarum Mle-3 increased the relative abundance of lactic acid bacteria in the intestines of aging mice, thereby achieving the ability to regulate the intestinal flora of mice and enhance host immunity.

[0075] Related research found that: Rhabditiaceae ( Muribaculaceae The relative content of ) is negatively correlated with constipation. Figure 5 As can be seen in the unclassified Rhabditiaceae ( unclassified_Muribaculaceae ), with the highest relative content in the aging model group (MC). It is speculated that the relative content of unclassified Bacillus species increased due to natural aging, which led to more severe constipation in aging mice. In the Mle-3 treatment group, the relative content of Bacillus species in the intestinal flora of aging mice was reduced by daily gavage of Lactobacillus plantarum Mle-3, which relieved the constipation of mice.

[0076] The UCG-001 family of the Prevotellaceae family ( Prevotellaceae_UCG_001 ) and the Prevotellaceae NK3B31 family ( Prevotellaceae_NK3B31_group ) has an important impact on the recovery of intestinal health and the production of anti-inflammatory factor IFN-γ in human health. Figure 5 As can be seen, the UCG-001 family of the Prevotellaceae family ( Prevotellaceae_ UCG_001 ) and the Prevotellaceae NK3B31 family ( Prevotellaceae_NK3B31_group ) had the lowest relative abundance in the aging model group (MC), and it is speculated that its abundance decreased due to natural aging. In the Mle-3 treatment group, daily gavage of Lactobacillus plantarum Mle-3 changed the intestinal flora of aging mice, resulting in an increase in its relative abundance, even exceeding that of the normal control group (CK), ultimately achieving the purpose of increasing the relative abundance of beneficial bacteria in the intestine, regulating the intestinal flora of mice, and promoting the growth of anti-inflammatory factors.

[0077] Helicobacter spp. Helicobacter ) is a common type of Gram-negative bacteria that can colonize the intestines and other organs of mammals and is currently one of the main bacterial genera that cause intestinal diseases. Figure 5 It can be seen that Helicobacter spp. Helicobacter ) had the highest relative content in the aging model group, suggesting that aging leads to an increase in Helicobacter in the intestines of mice. Daily oral administration of Lactobacillus plantarum Mle-3 can reduce its relative abundance, even to a level lower than that of the normal control group (CK), indicating that Lactobacillus plantarum Mle-3 can significantly inhibit the growth of Helicobacter in the intestines and maintain intestinal health.

[0078] In summary, Lactobacillus plantarum Mle-3 has a good colonization effect in the mouse intestine. It can not only scavenge free radicals in the mouse body and reduce their relative content, but also promote / inhibit the growth of microorganisms in the intestine, regulate the balance of intestinal flora, and reduce the risk of intestinal diseases.

[0079] "Aging begins in the intestines." During the aging process, excessive free radicals accelerate the aging of intestinal epithelial cells, increase the permeability of the intestinal wall, and reduce the barrier function.

[0080] like Figure 6 As shown in the figure, the colon mucosal layer structure of the normal control group (CK) mice was intact, the crypts were regular and a large number of goblet cells were visible, the crypt base was intact, and there was no infiltration of inflammatory cells in the mucosal layer and muscular layer. However, the mice in the aging model group (MC) showed damage to the mucosal layer structure, atrophy of the crypts, disappearance of goblet cells, and a large number of inflammatory cells infiltrated in the mucosal layer and crypt base.

[0081] Compared with the aging model group (MC), the mucosal layer structure of the mice in the Mle-3 treatment group (MLe-3) became complete, the crypts were regular and flat, the goblet cells increased, and the inflammatory cells in the mucosal layer, muscular layer, and crypt base disappeared. It can be seen that oral administration of Lactobacillus plantarum Mle-3 can improve the intestinal state of aging mice and restore the intestine to a youthful state.

[0082] Short chain fatty acids (SCFAs), also known as volatile fatty acids, are organic fatty acids composed of 1-6 carbon atoms, which can provide part of the energy required by the human body and regulate electrolyte balance, inhibit intestinal inflammation, have anti-tumor effects and regulate immune response. The applicant analyzed SCFAs in mouse cecal contents by GC-MS. Figures 7 to 9 As shown, the content of short-chain fatty acids in the Mle-3 treated group was higher than that in the aging model group (MC), and was basically the same as that in the normal control group (CK) mice, indicating that oral administration of Lactobacillus plantarum Mle-3 can restore the content of short-chain fatty acids in aging mice to a young state, thereby regulating the human immune response.

[0083] Among them, butyric acid and acetic acid have been related to the relief of constipation symptoms in previous related studies, and the content of butyric acid and acetic acid in the Mle-3 treatment group was higher, indicating that oral administration of Lactobacillus plantarum Mle-3 can relieve constipation caused by aging.

[0084] like Figures 10 to 13As shown, the serum glutathione peroxidase activity and glutathione peroxidase inhibition rate of mice in Mle-3 treatment group were higher than those in the normal control group and the aging model group, the serum superoxide anion inhibition activity and superoxide anion inhibition rate of mice in Mle-3 treatment group were higher than those in the normal control group and the aging model group, the serum catalase activity and hydroxyl free radical scavenging ability of mice in Mle-3 treatment group were higher than those in the normal control group and the aging model group, while the serum malondialdehyde content of mice in Mle-3 treatment group was lower than that in the normal control group and the aging model group, indicating that although the mice in Mle-3 treatment group were older, oral gavage with Lactobacillus plantarum Mle-3 could effectively improve the antioxidant capacity of mice, and restore their antioxidant capacity to at least the level of the normal control group.

[0085] Embodiment 7: A microbial composition comprising: the above-mentioned Lactobacillus plantarum Mle-3 and Lactobacillus plantarum MLL-6, and Bifidobacterium breve.

[0086] Among them, the viable count of Lactobacillus plantarum Mle-3 was 1×10 10 cfu / g, and the number of viable Lactobacillus plantarum MLL-6 was 4×10 9 cfu / g, and the number of viable bacteria of Bifidobacterium breve was 1.2×10 9 cfu / g.

[0087] Example 8: A composite microbial preparation, whose raw materials include: 1 g of the microbial composition obtained in Example 7, 1 g of sodium alginate, 1 g of 0.5-generation carboxyl-terminated polyamidoamine, 0.1 g of glutathione, 0.1 g of pine pollen polysaccharide, and 0.08 g of calcium chloride.

[0088] The preparation method of the above-mentioned composite microbial preparation comprises the following steps: S1. Add glutathione to 10 g of hydrochloric acid with a pH value of 5.2-5.6 and stir evenly, add pine pollen polysaccharide thereto, stir at a temperature of 80°C for 10 min, cool to room temperature, filter, wash, and vacuum dry to obtain an activated polypeptide; S2, adding the above-mentioned microbial composition, sodium alginate, carboxyl-terminated polyamidoamine, and activated polypeptide to 10 g of water, stirring at a speed of 500 r / min for 20 min to obtain an aqueous phase material; S3. Continue stirring 40 g of soybean oil at a stirring speed of 1000 r / min. During the continuous stirring process, add the aqueous phase material and an 8% by mass calcium chloride aqueous solution in sequence. After the addition is complete, continue stirring for 5 minutes. Let stand at 40°C for 2 hours, filter, wash, and freeze-dry.

[0089] Example 9: A composite microbial preparation, whose raw materials include: 2 g of the microbial composition obtained in Example 7, 2 g of sodium alginate, 3 g of 1.5-generation carboxyl-terminated polyamidoamine, 1 g of glutathione, 0.5 g of pine pollen polysaccharide, and 0.24 g of calcium chloride.

[0090] The preparation method of the above-mentioned composite microbial preparation comprises the following steps: S1. Add glutathione to 30 g of hydrochloric acid with a pH value of 5.2-5.6 and stir evenly, add pine pollen polysaccharide thereto, stir at a temperature of 90°C for 20 min, cool to room temperature, filter, wash, and vacuum dry to obtain an activated polypeptide; S2, adding the above-mentioned microbial composition, sodium alginate, carboxyl-terminated polyamidoamine, and activated polypeptide into 20 g of water, stirring at a speed of 800 r / min for 30 min to obtain an aqueous phase material; S3. Continuously stir 60 g of sunflower oil at a stirring speed of 2000 r / min. During the continuous stirring process, add the aqueous phase material and a 12% calcium chloride aqueous solution in sequence. After the addition is complete, continue stirring for 15 min. Let stand at 45 °C for 4 h, filter, wash, and freeze-dry.

[0091] Example 10: A composite microbial preparation, whose raw materials include: 1.5 g of the microbial composition obtained in Example 7, 1.5 g of sodium alginate, 2 g of 1.0 generation carboxyl-terminated polyamidoamine, 0.5 g of glutathione, 0.3 g of pine pollen polysaccharide, and 0.16 g of calcium chloride.

[0092] The preparation method of the above-mentioned composite microbial preparation comprises the following steps: S1. Add glutathione to 20 g of hydrochloric acid with a pH value of 5.2-5.6 and stir evenly, add pine pollen polysaccharide thereto, stir at a temperature of 85°C for 15 min, cool to room temperature, filter, wash, and vacuum dry to obtain an activated polypeptide; S2, adding the above-mentioned microbial composition, sodium alginate, carboxyl-terminated polyamidoamine, and activated polypeptide into 15 g of water, stirring at a speed of 600 r / min for 25 min to obtain an aqueous phase material; S3. Continue stirring 50 g of palm oil at a stirring speed of 1500 r / min. Add aqueous phase materials and 10% calcium chloride aqueous solution in sequence during the continuous stirring process. Continue stirring for 10 min after the addition is complete. Let stand at 42 °C for 3 h, filter, wash, and freeze-dry.

[0093] Comparative Example 1: A microbial composition comprising: the above-mentioned Lactobacillus plantarum Mle-3 and Bifidobacterium breve.

[0094] Among them, the viable count of Lactobacillus plantarum Mle-3 was 1×10 10 cfu / g, and the number of viable bacteria of Bifidobacterium breve was 1.2×10 9 cfu / g.

[0095] A composite microbial preparation, whose raw materials include: 1.5g of the microbial composition obtained in this comparative example, 1.5g of sodium alginate, 2g of 1.0-generation carboxyl-terminated polyamidoamine, 0.5g of glutathione, 0.3g of pine pollen polysaccharide, and 0.16g of calcium chloride.

[0096] The preparation method of the above-mentioned composite microbial preparation comprises the following steps: S1. Add glutathione to 20 g of hydrochloric acid with a pH value of 5.2-5.6 and stir evenly, add pine pollen polysaccharide thereto, stir at a temperature of 85°C for 15 min, cool to room temperature, filter, wash, and vacuum dry to obtain an activated polypeptide; S2. Add the microbial composition obtained in this comparative example, sodium alginate, carboxyl-terminated polyamidoamine, and activated polypeptide to 15 g of water, and stir at a speed of 600 r / min for 25 min to obtain an aqueous phase material; S3. Continue stirring 50 g of palm oil at a stirring speed of 1500 r / min. Add aqueous phase materials and 10% calcium chloride aqueous solution in sequence during the continuous stirring process. Continue stirring for 10 min after the addition is complete. Let stand at 42 °C for 3 h, filter, wash, and freeze-dry.

[0097] Comparative Example 2: A composite microbial preparation, whose raw materials include: 1.5 g of the microbial composition obtained in Example 7, 1.5 g of sodium alginate, 2 g of 1.0 generation carboxyl-terminated polyamidoamine, 0.5 g of glutathione, and 0.16 g of calcium chloride.

[0098] The preparation method of the above-mentioned composite microbial preparation comprises the following steps: S1. Add the above-mentioned microbial composition, sodium alginate, carboxyl-terminated polyamidoamine and glutathione to 15 g of water, and stir at a speed of 600 r / min for 25 min to obtain an aqueous phase material; S2. Continue stirring 50 g of palm oil at a stirring speed of 1500 r / min. Add aqueous phase materials and a 10% by mass calcium chloride aqueous solution in sequence during the continuous stirring process. Continue stirring for 10 min after the addition is complete. Let stand at 42 °C for 3 h, filter, wash, and freeze-dry.

[0099] A comparative experiment was conducted using the composite microbial preparations obtained in Example 10 and Comparative Examples 1-2, as follows: 1. Determination of embedding rate 1 g of each composite microbial preparation was added to an appropriate amount of 0.06 mol / L sodium citrate solution and mixed. The mixture was shaken at 180 r / min for 60 min in a constant temperature shaker at 37°C. The live Lactobacillus plantarum Mle-3 in each group was counted and the embedding rate was calculated.

[0100] Wherein, N is the number of live Lactobacillus plantarum Mle-3 released from the composite microbial preparation; N0 is the number of free Lactobacillus plantarum Mle-3 in the mixture during the production of the composite microbial preparation.

[0101] like Fig.14 As shown, the embedding rate of the composite microbial preparation obtained in Comparative Example 2 is the highest. However, the embedding rates of the composite microbial preparations obtained in Example 10 and Comparative Example 1 are lower, and there is no significant difference (P>0.05).

[0102] This is because Example 10 and Comparative Example 1 use active polysaccharides grafted onto glutathione, which reduces their embedding rates.

[0103] 2. Bile salt tolerance test Each group of composite microbial preparations (wherein the concentration of Lactobacillus plantarum Mle-3 was 1×10 10 cfu / g) was inoculated into MRS liquid medium with a bile salt concentration of 0.3% (w / v) at a volume fraction of 10%, and then placed in a 37°C incubator for 4 hours. Then, an appropriate amount of 0.06 mol / L sodium citrate solution was added and mixed, and the mixture was shaken at a speed of 180 r / min for 60 minutes in a 37°C constant temperature shaker, and the live Lactobacillus plantarum Mle-3 in each group was counted.

[0104] like Fig.15 As shown, the composite microbial preparations obtained in Example 10 and Comparative Example 1 still maintained high activity after bile salt treatment, but there was no significant difference between the two (P>0.05). In Comparative Example 2, since the active polysaccharide was not grafted onto glutathione, its embedding wall material was not tight enough, resulting in a significant decrease in the number of live Lactobacillus plantarum Mle-3 after bile salt treatment.

[0105] 3. In vitro simulated digestive fluid tolerance test The simulated gastric fluid used was as follows: 0.5% NaCl solution was adjusted to pH 2.0 with 1 mol / L hydrochloric acid, pepsin was added to make the final concentration of the enzyme in the solution 3.0 g / L, and then sterilized by filtration with a 0.22 μm aqueous phase filter membrane.

[0106] The simulated intestinal fluid used was as follows: Trypsin, bile salts and phenol were added to 0.5% NaCl solution to make them evenly dispersed, and the final concentrations were 1.0 g / L, 5.0 g / L and 4.0 g / L, respectively. The pH value of the system was adjusted to 8.0 with 1 mol / L NaOH solution, and then filtered and sterilized with a 0.22 μm aqueous phase filter membrane.

[0107] Take 1g of each group of composite microbial preparations, add to 9mL of simulated gastric fluid, shake and mix the microcapsules and artificial gastric fluid evenly, then shake at 160r / min in a constant temperature shaker at 37±1℃, centrifuge after 180min to discard the simulated gastric fluid, add 9mL of simulated intestinal fluid, shake and mix the remaining composite microbial preparations and artificial intestinal fluid evenly, then shake at 160r / min in a constant temperature shaker at 37±1℃, and count after 420min.

[0108] For counting, the remaining composite microbial preparation was washed with physiological saline, dissolved in 9 mL of 0.06 mol / L sodium citrate solution, and after gradient dilution, live bacteria were counted using the spread plate method.

[0109] Among them, A1 is the number of Lactobacillus plantarum Mle-3 cells during the test, cfu / g; A0 is the number of Lactobacillus plantarum Mle-3 cells at the beginning of digestion, cfu / g.

[0110] like Fig.16 As shown, the composite microbial preparations obtained in Example 10 and Comparative Example 1 still maintained high activity after being treated with simulated digestive fluid, but there was no significant difference between the two (P>0.05).

[0111] In Comparative Example 2, since no active polysaccharide was grafted onto glutathione, the embedding wall material was not tight enough, resulting in a significant decrease in the number of live Lactobacillus plantarum Mle-3 after being exposed to simulated digestive fluid.

[0112] 4. Antioxidant effect in aging mice Twenty-four 40-week-old male C57BL6 mice were randomly divided into three groups, namely SS10, DB1 and DB2, with 4 animals per cage in each group. The room temperature was 23-25℃, the humidity was 40-45%, the light was on for 12 hours per day, and the mice were allowed to eat and drink freely. The bedding was changed regularly, and the mice were gavaged once a day at a fixed time. The mice were adaptively fed for 1 week, and the intervention lasted for 14 weeks (98 days).

[0113] The groups and interventions are shown in Table 2: Table 2 Intervention treatments in SS10, DB1 and DB2 groups: Wherein, the basic feed is the same as that in Example 6.

[0114] The normal control group and the aging model group continued to use the data in Example 6 above.

[0115] like Fig.17 , Fig.18 , Fig. 20 and Fig. 22 As shown, the serum glutathione peroxidase activity and glutathione peroxidase inhibition rate of mice in SS10 group, DB1 group and DB2 group were higher than those in the normal control group and the aging model group, the serum superoxide anion inhibition activity and superoxide anion inhibition rate of mice in SS10 group, DB1 group and DB2 group were higher than those in the normal control group and the aging model group, the serum catalase activity and hydroxyl free radical scavenging ability of mice in SS10 group, DB1 group and DB2 group were higher than those in the normal control group and the aging model group, while the serum malondialdehyde content of mice in SS10 group, DB1 group and DB2 group was lower than that in the normal control group and the aging model group. This indicates that although the mice in SS10 group, DB1 group and DB2 group were older, oral administration of the composite microbial preparation can effectively improve the antioxidant capacity of mice and restore their antioxidant capacity to at least the level of the normal control group.

[0116] like Fig.17 , Fig.19 , Fig.21 and Fig. 22 As shown, the serum glutathione peroxidase activity and glutathione peroxidase inhibition rate of mice in SS10 group were higher than those in DB1 group and DB2 group, the serum superoxide anion inhibition activity and superoxide anion inhibition rate of mice in SS10 group were higher than those in DB1 group and DB2 group, the serum catalase activity and hydroxyl radical scavenging ability of mice in SS10 group were higher than those in DB1 group and DB2 group, while the serum malondialdehyde content of mice in SS10 group was lower than that in DB1 group and DB2 group, which confirmed that the composite microbial preparation obtained by oral administration of Example 10 can more effectively improve the antioxidant capacity of mice, and also confirmed that the compound of Lactobacillus plantarum Mle-3, Lactobacillus plantarum MLL-6 and Bifidobacterium breve can better enhance the antioxidant capacity of mice.

[0117] The serum antioxidant indexes of mice in the SS10 group, DB1 group and DB2 group were compared with those in the Mle-3 treatment group in Example 6. It was found that the serum antioxidant index of mice in the DB1 group was better than that in the Mle-3 treatment group. This indicates that the use of the composite microbial preparation can effectively help the microbial composition (especially Lactobacillus plantarum Mle-3) pass through the digestive juice, which is beneficial to the colonization of the microbial composition in the intestine and improves the body's antioxidant capacity.

[0118] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.

Claims

1. Lactobacillus plantarum Lactiplantibacillus plantarum ) Application of Mle-3 in any of the following (1)-(5): (1) Preparation of antioxidant products; (2) Preparation of anti-aging products; (3) preparing products for repairing colon mucosa; (4) Preparation of Helicobacter spp. Helicobacter ) and / or unclassified Rhabditiaceae ( unclassified_Muribaculaceae ) products grown; (5) Preparation of the UCG-001 family of the family Prevotellaceae to promote intestinal Prevotellaceae_UCG_001 ) or / and Prevotellaceae NK3B31 family ( Prevotellaceae_NK3B31_group ) products grown.

2. The application according to claim 1, characterized in that: Lactobacillus plantarum Mle-3 is deposited in the General Microbiology Center of China Microorganism Culture Collection Administration with the deposit number of CGMCC NO.30556.

3. The application according to claim 1, characterized in that: The products are microbial preparations, health foods or medicines.

4. A microbial composition, characterized in that include: The use of Lactobacillus plantarum Mle-3 as claimed in claim 1.

5. The microbial composition according to claim 4, characterized in that: Also includes: Lactobacillus plantarum ( Lactiplantibacillus plantarum )MLL-6, Bifidobacterium breve ( Bifidobacterium breve ); Among them, the viable count of Lactobacillus plantarum Mle-3 was 5-15×10 9 cfu / g, and the number of viable bacteria of Lactobacillus plantarum MLL-6 was 2-6×10 9 cfu / g, the number of viable bacteria of Bifidobacterium breve is 9-14×10 8 cfu / g.

6. A composite microbial preparation, characterized in that: The raw materials include, by mass: 1-2 parts of the microbial composition as claimed in claim 4 or 5, 1-2 parts of sodium alginate, 1-3 parts of carboxyl-terminated polyamidoamine, 0.1-1 parts of glutathione, 0.1-0.5 parts of active polysaccharide, and 0.08-0.24 parts of calcium chloride.

7. The composite microbial preparation according to claim 6, characterized in that: The active polysaccharide is pine pollen polysaccharide.

8. A method for preparing the composite microbial preparation according to claim 6 or 7, characterized in that: The steps include: S1. Add glutathione to hydrochloric acid and stir evenly, add pine pollen polysaccharide thereto, stir at 80-90°C for 10-20 minutes, cool to room temperature, filter, wash, and vacuum dry to obtain activated polypeptide; S2, adding the microbial composition as claimed in claim 4 or 5, sodium alginate, carboxyl-terminated polyamidoamine, and activated polypeptide into water and stirring for 20-30 minutes to obtain an aqueous phase material; S3. Continue stirring the oil phase, and add the water phase material and calcium chloride aqueous solution in sequence during the continuous stirring process. Continue stirring for 5-15 minutes after the addition is complete, let stand at 40-45°C for 2-4 hours, filter, wash, and freeze-dry.

9. The method for preparing the composite microbial preparation according to claim 8, characterized in that: In S3, the oil phase is at least one of peanut oil, rapeseed oil, soybean oil, corn oil, camellia oil, walnut oil, olive oil, palm oil, grape seed oil, and sunflower seed oil.

10. The method for preparing the composite microbial preparation according to claim 8, characterized in that: In S3, the mass fraction of the calcium chloride aqueous solution is 8-12%.

Citation Information

Patent Citations

  • Chitosan derivative with mucosal adhesion and Pept-1 targeting performance and preparation method thereof

    CN107903337A

  • Dendrimer compositions and use in treatment of necrotizing enterocolitis and other gastrointestinal disorders

    CN108289872A

  • Preparation method of suckling pig feed added with enteric composite microecological preparation

    CN109527238A

  • Application of lactobacillus plantarum in regulating intestinal flora

    CN115500515A

  • Preparation method of space-time positioning device with probiotics wrapped by multilayer copolymer

    CN115581685A